Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
PRLD | Prelude Therapeutics Inc | Scherle Peggy | Chief Scientific Officer | Aug 26, 2021 | Option Exercise | $18.31 | 3,400 | 62,250 | 174,620 | Aug 30, 2021, 05:16 PM | |
PRLD | Prelude Therapeutics Inc | Scherle Peggy | Chief Scientific Officer | Aug 27, 2021 | Sale | $18.67 | 12,028 | 224,567 | 178,934 | Aug 30, 2021, 05:16 PM | |
PRLD | Prelude Therapeutics Inc | Scherle Peggy | Chief Scientific Officer | Aug 13, 2021 | Option Exercise | $18.30 | 4,572 | 83,687 | 175,206 | Aug 17, 2021, 04:44 PM | |
PRLD | Prelude Therapeutics Inc | Scherle Peggy | Chief Scientific Officer | Jul 27, 2021 | Sale | $18.45 | 40,000 | 737,980 | 192,920 | Jul 29, 2021, 07:27 PM | |
PRLD | Prelude Therapeutics Inc | Scherle Peggy | Chief Scientific Officer | May 07, 2021 | Sale | $21.12 | 20,000 | 422,492 | 182,920 | May 11, 2021, 06:46 PM | |
PRLD | Prelude Therapeutics Inc | Scherle Peggy | Chief Scientific Officer | Apr 07, 2021 | Sale | $20.37 | 30,740 | 626,123 | 188,290 | Apr 09, 2021, 05:55 PM |